Skip to main content
NCBI home page
Public Health Reports logoLink to Public Health Reports
. 1993 Jul-Aug;108(4):431–435.

Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.

T R Coté 1, D Sivertson 1, J M Horan 1, M L Lindegren 1, D M Dwyer 1
PMCID: PMC1403404  PMID: 8341775

Abstract

Despite high vaccination levels, measles outbreaks continue to occur among vaccinated adults. In response, new guidelines call for two doses of measles vaccine. To determine seroprevalence and response to vaccination in seronegative persons, we tested serums from 256 college athletes at a Maryland State college by enzyme-linked immunosorbent assay, vaccinated seronegatives, then re-tested vaccinees. High school records were obtained for persons seronegative to measles. Of 256 students, 53 (21 percent) were seronegative to measles alone, 13 (5 percent) were seronegative to rubella alone, and 5 (2 percent) were seronegative to both. Among those seronegative to measles, 86 percent had previously received a dose of measles vaccine. After vaccination, 37 persons initially seronegative to measles and 9 seronegative to rubella were 97 percent and 100 percent seropositive, respectively. The high measles seroconversion rate suggests that the two-dose vaccine schedule should effectively control campus measles outbreaks and, if given as measles-mumps-rubella vaccine, will also improve immunity to rubella and mumps.

Full text

PDF
431

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braunstein H., Thomas S., Ito R. Immunity to measles in a large population of varying age. Significance with respect to vaccination. Am J Dis Child. 1990 Mar;144(3):296–298. doi: 10.1001/archpedi.1990.02150270046024. [DOI] [PubMed] [Google Scholar]
  2. Chen R. T., Markowitz L. E., Albrecht P., Stewart J. A., Mofenson L. M., Preblud S. R., Orenstein W. A. Measles antibody: reevaluation of protective titers. J Infect Dis. 1990 Nov;162(5):1036–1042. doi: 10.1093/infdis/162.5.1036. [DOI] [PubMed] [Google Scholar]
  3. Chou T., Weil D., Arnow P. M. Prevalence of measles antibodies in hospital personnel. Infect Control. 1986 Jun;7(6):309–311. doi: 10.1017/s0195941700064328. [DOI] [PubMed] [Google Scholar]
  4. Christenson B., Böttiger M., Heller L. Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience. Br Med J (Clin Res Ed) 1983 Aug 6;287(6389):389–391. doi: 10.1136/bmj.287.6389.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gustafson T. L., Lievens A. W., Brunell P. A., Moellenberg R. G., Buttery C. M., Sehulster L. M. Measles outbreak in a fully immunized secondary-school population. N Engl J Med. 1987 Mar 26;316(13):771–774. doi: 10.1056/NEJM198703263161303. [DOI] [PubMed] [Google Scholar]
  6. Hinman A. R., Brandling-Bennett A. D., Nieburg P. I. The opportunity and obligation to eliminate measles from the United States. JAMA. 1979 Sep 14;242(11):1157–1162. [PubMed] [Google Scholar]
  7. Krause P. J., Cherry J. D., Deseda-Tous J., Champion J. G., Strassburg M., Sullivan C., Spencer M. J., Bryson Y. J., Welliver R. C., Boyer K. M. Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med. 1979 Jun;90(6):873–876. doi: 10.7326/0003-4819-90-6-873. [DOI] [PubMed] [Google Scholar]
  8. Markowitz L. E., Preblud S. R., Orenstein W. A., Rovira E. Z., Adams N. C., Hawkins C. E., Hinman A. R. Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med. 1989 Jan 12;320(2):75–81. doi: 10.1056/NEJM198901123200202. [DOI] [PubMed] [Google Scholar]
  9. Neumann P. W., Weber J. M., Jessamine A. G., O'Shaughnessy M. V. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol. 1985 Aug;22(2):296–298. doi: 10.1128/jcm.22.2.296-298.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Orenstein W. A., Markowitz L., Preblud S. R., Hinman A. R., Tomasi A., Bart K. J. Appropriate age for measles vaccination in the United States. Dev Biol Stand. 1986;65:13–21. [PubMed] [Google Scholar]
  11. Rabo E., Taranger J. Scandinavian model for eliminating measles, mumps, and rubella. Br Med J (Clin Res Ed) 1984 Nov 24;289(6456):1402–1404. doi: 10.1136/bmj.289.6456.1402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shasby D. M., Shope T. C., Downs H., Herrmann K. L., Polkowski J. Epidemic measles in a highly vaccinated population. N Engl J Med. 1977 Mar 17;296(11):585–589. doi: 10.1056/NEJM197703172961102. [DOI] [PubMed] [Google Scholar]
  13. Watkins N. M., Smith R. P., Jr, St Germain D. L., MacKay D. N. Measles (rubeola) infection in a hospital setting. Am J Infect Control. 1987 Oct;15(5):201–206. doi: 10.1016/0196-6553(87)90096-4. [DOI] [PubMed] [Google Scholar]
  14. Weigle K. A., Murphy M. D., Brunell P. A. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J Clin Microbiol. 1984 Mar;19(3):376–379. doi: 10.1128/jcm.19.3.376-379.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Public Health Reports are provided here courtesy of SAGE Publications

RESOURCES